Key statistics
As of last trade, Cognition Therapeutics Inc (CGTX:NMQ) traded at 0.433, 27.35% above the 52 week low of 0.34 set on Oct 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.4791 |
---|---|
High | 0.4791 |
Low | 0.421 |
Bid | 0.4328 |
Offer | 0.4332 |
Previous close | 0.4277 |
Average volume | 388.81k |
---|---|
Shares outstanding | 40.13m |
Free float | 39.91m |
P/E (TTM) | -- |
Market cap | 17.16m USD |
EPS (TTM) | -0.9553 USD |
Data delayed at least 15 minutes, as of Nov 25 2024 14:52 GMT.
More ▼
- Cognition Therapeutics Reports Financial Results for the Third Quarter 2024 and Provides Business and Clinical Update
- Cognition Therapeutics Reports Financial Results for the Second Quarter 2024 and Provides Business and Clinical Update
- Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update
- Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference
- Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
- Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
- Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock
- Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock
- Cognition Therapeutics Announces Proposed Public Offering of Common Stock
- Cognition Therapeutics to Present at the TD Cowen Health Care Conference
More ▼